Colon cancer prevention with NO-releasing NSAIDs
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 67 (2) , 107-120
- https://doi.org/10.1016/s0090-6980(02)00003-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 InhibitorAmerican Journal of Gastroenterology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trialArthritis & Rheumatism, 2000
- Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complicationsThe American Journal of Medicine, 1999
- In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016Thrombosis Research, 1999
- Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions.Gastroenterology, 1997
- Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred yearsGastroenterology, 1997
- Effect of single and repeated doses of a new nitroderivative of acetylsalicylic acid on platelet TXA2 production in ratsLife Sciences, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996